Nivolumab and ipilimumab combination for advanced skin cancer

Dr Larkin presents results from Checkpoint 067, a trail of combined nivolumab and ipilimumab for advanced melanoma, at AACR 2017. Slides from this presentation are available here, and you can read more about the results here. Dr Suzanne Topalian spoke...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o5rmF3
via IFTTT